Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia
Clinical trial NCT05906914 · COMPLETED
Trial details
- NCT number
- NCT05906914
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2025-04-11
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.